Ideas that connect innovation
to enterprise value.
Practical perspectives on AI, MedTech performance, growth, and investment.

The next MedTech advantage:
AI that reaches the P&L.
The opportunity extends beyond smarter products. It lies in connecting AI to the workflows, decisions, and operating capabilities that shape business performance.
AI & enterprise transformationPerspectives for leaders and investors.

Start with the workflow, not the tool.
Identify a costly decision or recurring task before choosing technology. Assess data readiness, adoption, oversight, and the business measure that will define success.

Lifecycle friction is a business issue.
Slow handoffs across development, regulatory, quality, and operations can constrain performance. Map the full workflow and assign ownership across functions.

Build readiness into transformation.
Evaluate quality, regulatory, and validation needs early. Align intended use, controls, evidence, and human accountability before scaling new capabilities.

Look beyond the cost line.
Product mix, pricing, yield, capacity, and cost-to-serve all shape margins. Examine them together to distinguish local savings from enterprise value.

Make growth an operating capability.
Connect market opportunity and customer adoption with product readiness, supply, and execution capacity. Track commercial and operating outcomes together.

Test the value-creation thesis early.
Assess operating scalability alongside market attractiveness. Translate diligence findings into clear priorities, dependencies, ownership, and measures.
Therion perspectives are general viewpoints, not investment, legal, or regulatory advice.
From perspective to a practical roadmap.
Explore our approach to connecting AI opportunities across the product lifecycle with business value.
Explore MedTech Renaissance →Turn insight into action.
Discuss what these perspectives could mean for your business or portfolio.